RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
about
NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's diseaseNanoparticle transport across the blood brain barrier.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.Molecular chaperones as rational drug targets for Parkinson's disease therapeutics.Drug targets from genetics: α-synuclein.Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.Silencing of Hsp90 chaperone expression protects against 6-hydroxydopamine toxicity in PC12 cells.
P2860
Q36089698-22165979-09FB-4D16-961F-8CEFA2268D13Q36812347-EC17139B-0842-4F8D-B879-2DB12339C7FDQ37416147-B7586322-1B36-4012-B873-4832EBE2232BQ37578490-90259671-0F28-4C86-9CAD-6D4C04DDE94FQ37799850-C527CCF8-4F45-4099-B130-861739468CB3Q37916635-ECB58C0F-FE7F-4D68-8A13-1A719A2257ADQ38091009-77B65145-8614-4B1D-BE7F-A233605E65A3Q38713790-D24669F1-1D80-456F-B583-FA08D796D571Q45813546-F5660DED-C25F-473F-9F3D-F33C06930E3C
P2860
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@ast
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@en
type
label
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@ast
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@en
prefLabel
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@ast
RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
@en
P2860
P356
P1433
P1476
RNA knockdown as a potential therapeutic strategy in Parkinson's disease
@en
P2093
Manfredsson FP
P2860
P2888
P304
P356
10.1038/SJ.GT.3302669
P577
2006-03-01T00:00:00Z